CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected By The Pandemic Read more
Lineage Cell Therapeutics Announces Early Exercise of Option with Cancer Research UK for Immuno-Oncology Cell Therapy Program Read more
Bicycle Therapeutics Announces First Patient Dosed in Phase I Dose Escalation of BT5528 in Combination with Nivolumab Read more